Liver Cancer in the Middle East
Description
This book aims to illuminate the causes, incidence, and treatments of Hepatocellular Carcinoma(HCC) or liver cancer in the politically important and societally diverse region of the Middle East. Taking a flexible and inclusive view, it examines the influences of geography, crops and diet, ethnicity, and local behavior on both diagnosis and outcomes of this disease. Understanding the different causes of liver cancer enables effective strategies for both prevention and early diagnosis while knowledge of the different treatment modalities, their uses and limitations, availability and costs, works to inform rational treatment provision and selection. Divided into four sections, this book considers the causes and clinical syndromes associated with HCC, provides a detailed overview of clinical HCC and treatment modalities, describes country-specific clinical HCC experience and practice, and considers future needs and the potential for HCC collaborations across the region.
Liver Cancer in the Middle East is a useful resource for clinicians seeking insight into the second highest cause of death from cancer worldwide, governments planning social and medical services for their peoples, as well as for international aid agencies prioritizing donations.
Reviews / Votes
"This book is a delight, clear, and easy to read and digest. The reader of this book will gain insights into the societies and their mores in a politically very important part of the world . . the current book . is highly recommended." (Ignazio R. Marino, Journal of Gastrointestinal Cancer, Vol. 54 (2), 2023)More details
Other editions
Additional editions
Person
Brian I. Carr
Professor, Team Leader in Translational HCC Research
Liver Transplantation Institute
Inonu University, Malatya
Turkey
